Unlearn AI: Difference between revisions
Added business details: founded 2019, funding $50M Series C |
Added cross-references: AIDAVA Competitive Analysis, Triall |
||
| Line 27: | Line 27: | ||
== See Also == | == See Also == | ||
* [[AIDAVA Competitive Analysis]] | |||
* [[Triall]] | |||
* [[AIDAVA]] | * [[AIDAVA]] | ||
* [[AIDAVA Related Companies]] | * [[AIDAVA Related Companies]] | ||
Latest revision as of 17:57, 14 April 2026
What They Do[edit]
Generates AI digital twins from clinical data to optimize clinical trials. Uses patient longitudinal data for prediction and generates synthetic control arms, reducing trial sizes and timelines.
AIDAVA Relevance[edit]
Longitudinal patient data for digital twins, synthetic data generation
Funding[edit]
Valuation: ~$200M+ (est.) $50M+
Business Details[edit]
- Founded: 2019
- Total Funding: $50M Series C
- Valuation: ~$200M+ (est.)
- Revenue: N/A (private)
- Employees: ~50-100 (est.)
- Key Milestones: $50M Series C. Digital twins for clinical trials. Applied to VectorY PIONEER-ALS study.